Skip to main content

Medicines and Older People with Diabetes: Beliefs, Benefits and Risks

  • Chapter
  • First Online:
The Art and Science of Personalising Care with Older People with Diabetes

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 49.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 49.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Australian Commission on Safety and Quality in Healthcare (ACSQHC) (2011) National Safety and Quality Health Service Standards. ACSQHC, Canberra, pp 34–39

    Google Scholar 

  • Australian Institute of Health and Welfare (AIHW) (2009) Australian hospital statistics 2007–8. AIHW, Canberra

    Google Scholar 

  • Cheek D, Basshore L, Brazeau D (2015) Pharmacogenomic and implications for nursing practice. J Nurs Scholarsh 47(6):496–504

    Article  PubMed  Google Scholar 

  • Commonwealth Department of Health and Aging (2002) The quality use of medicines. Commonwealth Department of Health and Aging, Canberra

    Google Scholar 

  • Cramer J, Roy A, Burrell A, Fairchild C, Fuldeore M, Ollendorf D, Wong P, International Society for Pharmacoeconomics for Outcomes Research Working Group (2007) Medication compliance and persistence: terminology and definitions. Value Health 11(1):4447

    Google Scholar 

  • Cryer P, Davis S, Shamoon H (2003) Hypoglycaemia in diabetes. Diabetes Care 26(6):1902–1912. www.health.gov.au/internet/main/publishing.nsf/content/nmp-quality.htm

    Article  CAS  PubMed  Google Scholar 

  • Davis T, Federman A, Bass P, Jackson R et al (2009) Improving patient understanding of prescription drug label instructions. J Gen Intern Med 24:57–62

    Article  PubMed  Google Scholar 

  • Di Matteo M, Giordani P, Lepper H, Croghan T (2002) Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 40(9):794–811

    Article  Google Scholar 

  • Diabetes Australia. (DA) (2011) A new language for diabetes: improving communication with and about people with diabetes. DA, Canberra

    Google Scholar 

  • Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the progression of long term complications of insulin dependent diabetes. N Engl J Med 329:977–986

    Article  Google Scholar 

  • Dickinson J, Guzman S, Melinda D et al (2017) The use of language in diabetes care and education. Diabetes Care. care.diabetesjournals.org/content/early/2017/09/26/dci17-0041

    Google Scholar 

  • Dooley M, Wiseman M, McRae A et al (2011) Reducing potentially fatal errors associated with high doses of insulin: a successful multifaceted multidisciplinary prevention strategy. Br Med J. https://doi.org/10.1136/bmjqs.2010.049668

  • Dunning T (2003) Complementary therapies and diabetes. Complement Ther Nurs Midwifery 9:74–80

    Article  PubMed  Google Scholar 

  • Dunning T, Manias E (2005) Medication knowledge and self-management by people with Type 2 diabetes. Aust J Adv Nurs 11:172–181

    Google Scholar 

  • Dunning T, Sinclair S (2014) Glucose lowering medicines and older people with diabetes: the importance of comprehensive assessments and pharmacovigilance. J Nurs Care 3(3):1–9

    Google Scholar 

  • Dunning T, Savage S, Duggan N. (2013) The McKellar guidelines for managing older people with diabetes.in residential and other care settings. http://www.adma.org.au/clearinghouse/doc_details/133-the-mckellar-guidelines-for-managing-older-people-with-diabetes-in-residential-and-other-care-settings_9dec2013.html

  • Dunning T, Speight J, Bennett C (2017) Language, the ‘diabetes restricted code/dialect,’ and what it means for people with diabetes and clinicians. Diabetes Educ 47(1):18–26

    Article  Google Scholar 

  • Egede L, Xiaobou Y, Zheng D, Silverstein M (2002) The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care 25:324–329

    Article  PubMed  Google Scholar 

  • Eldred B, Dean A, McGuire T, Nash A (2006) Vaccine components and constituents: responding to consumer concerns. Med J Aust 2184(4):170–175

    Google Scholar 

  • Evrard A, Mbatchi L (2012) Genetic polymorphisms of drug metabolizing enzymes and transporters. The long way from bench to bedside. Curr Top Mol Chem 12(15):1720–1729

    Article  CAS  Google Scholar 

  • Family Caregiver Alliance (2010) http://www.caregiver.org/caregiver/jsp/content_node.jspp?nodeid=1822

  • Fowler D. Rayman G. (2010) Safe and effective use of insulin in hospitalised patients. National Health Service London. http://www.diabetes.nhs.uk/document.php?o=1040. Accessed Jan 2011

  • Glisky E, Rubin S, Davidson S (2001) Source memory in older adults: an encoding or retrieving problem. J Exp Psychol 27(5):1131–1146

    CAS  Google Scholar 

  • Green J, Hawley J, Rask K (2007) Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother 5(1):31–39

    Article  PubMed  Google Scholar 

  • Hilmer S, Gnijidic D, Le Couteur D (2013) Thinking through the medication list. Aust Fam Physician 12:924–928

    Google Scholar 

  • Institute of Safe Medicine Practice (ISMP) 2008. www.ismp.org . Accessed Jan 2011.

  • International Diabetes Federation (IDF) (2013) Language philosophy. www.idf.org

  • Jenkins R, Vaida A. (2007) Simple strategies to avoid medication errors. AAFP http://www.aafp.org/fpm/2007/0200p41.html . Accessed Dec 2009.

  • Johnson J (2011) Drug target pharmacogenetics. Am J Pharmacogenomics 4:315–322

    Google Scholar 

  • Li F, Harmer P, Fisher J et al (2005) Tai chi and fall reduction in older adults: a randomized controlled trial. J Gerontol: Med Sci 60A(2):187–194

    Article  Google Scholar 

  • Lim L, McStea M, Chung W et al (2017) Prevalence, risk factors and health outcomes associated with polypharmacy among urban community-dwelling older adults in multi-ethnic Malaysia. PLoS One. https://doi.org/10.1371/journal.pone.0173466

  • Mallikarjun V, Swift J (2016) Therapeutic manipulation of ageing: repurposing old dogs and discovering new tricks. EBioMedicnine. https://doi.org/10.1016/j.ebiom.2016.11.o2o

  • Manya K, Champion B, Dunning T (2012) The use of complementary and alternative medicine among people living with diabetes in Sydney. BMC Complement Altern Med. https://doi.org/10.1166/1472-6882-12-2

  • Mosby’s Medical Dictionary (2009) 8th ed. Elservier.

    Google Scholar 

  • National Heart Foundation of Australia (NHFA) (2011) Improving Adherence in cardiovascular care. NHFA

    Google Scholar 

  • Newman B. (2010) Safety first. Nursing Rev 26

    Google Scholar 

  • O’Mahony D, O’Sullivan D, Byrne S et al (2015) STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44(2):213–218. https://doi.org/10.1093/ageing/afu145

    Article  PubMed  Google Scholar 

  • Palliative Care—palliAGED (2017). https://www.palliaged.com.au/tabid/4338/Default.aspx

  • Pearson E (2016) Personalized medicine in diabetes: the role of ‘omics’ and biomarkers. Diabet Med 13(6):712–717

    Article  CAS  Google Scholar 

  • Rogers E, Yost K, Rosedahl J et al (2017) Validating the patient experience with treatment self-management (PETS), a patient-reported measure of treatment burden, in people with diabetes. Patient Rel Outcome Meas 8:143–156

    Article  Google Scholar 

  • Rommers M, Teepe-Twiss I, Guchelaar H-J (2007) Preventing adverse drug events in hospital practice: an overview. Pharmacepidemiol Drug Saf 16:1129–1135

    Article  Google Scholar 

  • Roughead E, Lexchin J (2006) Adverse drug events: counting s not enough, action is needed. Med J Aust 184(7):315–316

    PubMed  Google Scholar 

  • Sav A, Whitty J, McMillan S et al (2016) Treatment burden and chronic illness: who is most at risk? Patient 9(6):559–569

    Article  PubMed  Google Scholar 

  • Savage S, Dunning T, Duggan N, Martin P (2012) The experiences and care preferences of people with diabetes at the end of life. J Hospice Palliative Care Nurs. https://doi.org/10.1097/NJH.0601e3184bdb39

  • Shrank W, Libeman J, Fischer M, Kiabuk E, Girdish C, Curtrona S, Brennan T, Chudhry N (2011) Are caregivers adherent to their own medications? J Am Pharm Assoc 51(4):492–498

    Article  Google Scholar 

  • Simpson S, Eurich D, Sadjeedp S, Ross I, Varney J, Johnson J (2006) A meta-analysis of the association between adherence to drug therapy and mortality. Br Med J 333:15–18

    Article  Google Scholar 

  • Sissung T, Goey A, Ley A et al (2014) Pharmacogenetics of membrane transporters: a review of current approaches. Methods Mol Biol 1175:91–120

    Article  CAS  PubMed  Google Scholar 

  • Stowasser D, Allison Y, O’Leary Karen M (2004) Understanding the medicine management pathway. J Pharmacol Pract Res 34:293–296

    Article  Google Scholar 

  • The Pharmacy Guild of Australia (2010) Medindex: a medicine compliance indicator. The Pharmacy Guild of Australia, Canberra. http://www.medsindex.com.au

    Google Scholar 

  • United Kingdom National Prescribing Centre (2004) Task Force on Medicines Partnership. Drugs of porcine origin and their clinical alternatives. An introductory guide; March 2004. Available from: http://www.mcb.org.uk/uploads/PBEnglish.pdf

  • United Kingdom Prospective Study (UKPDS 33, 34) (1998) Intensive blood glucose control. Lancet 352(837–853):854–865

    Google Scholar 

  • Williams A, Manias E, Walker R (2008) Interventions to improve medication adherence in people with multiple chronic conditions: a systematic review. J Adv Nurs 63(2):132–143

    Article  PubMed  Google Scholar 

  • Wolfstadt J, Gurwitz J, Field T, Lee M, Kalkar S, Wu W, Rochon P (2008) The effect of computerized physician order entry and clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med 23(4):451–458

    Article  PubMed  PubMed Central  Google Scholar 

  • World health Organisation (WHO) (2003) Adherence to long-term therapies: evidence for action. WHO, Geneva

    Google Scholar 

  • Yasuda S, Zhang L, Huang S-M (2016) The role of ethnicity in variability in response to drugs: focus on clinical pharmacology. Stud Nat Pharmacol. http://www.tda.gov.downlods/Drugs/ScienceResearch/.../UCM0865502.pdf

  • Young-Hyman D, de Groot M, Hill-Briggs E et al (2016) Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care 29(12):2126–2140

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Trisha Dunning A.M., M.Ed., Ph.D., R.N., C.D.E. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dunning, T. (2018). Medicines and Older People with Diabetes: Beliefs, Benefits and Risks. In: Dunning, T. (eds) The Art and Science of Personalising Care with Older People with Diabetes. Springer, Cham. https://doi.org/10.1007/978-3-319-74360-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-74360-8_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-74359-2

  • Online ISBN: 978-3-319-74360-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics